Preferred Label : betahistine;

MeSH definition : A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.;

CISMeF synonym : 5579-84-0 (Betahistine hydrochloride); ergha brand of betahistine hydrochloride; fides ecopharma brand of betahistine hydrochloride; bouchara brand of betahistine hydrochloride; solvay brand of betahistine hydrochloride; unimed brand of betahistine hydrochloride; eurim brand of betahistine hydrochloride; byk gulden brand of betahistine hydrochloride; gerard brand of betahistine hydrochloride; aliud brand of betahistine mesylate; stadapharm brand of betahistine mesylate; ratiopharm brand of betahistine mesylate; hennig brand of betahistine mesylate; dexo brand of betahistine mesylate; medopharm brand of betahistine mesylate; altana pharma brand of betahistine mesylate;

MeSH hyponym : Betahistine Mesylate; fidium; vertigon; serc; betahistin stada; mersilon; betavert; lectil; By-Vertin; ribrain; PT-9; betahistin AL; extovyl; Betahistine Hydrochloride; betahistin-ratiopharm; aequamen; betahistine dihydrobromide; melopat; Betahistin Ratiopharm; Dihydrobromide, Betahistine; Hydrochloride, Betahistine; Betahistine Dihydrochloride; Dihydrochloride, Betahistine; Mesylate, Betahistine; Betahistine Methanesulphonate; Methanesulphonate, Betahistine; Betahistine Methanesulfonate; Methanesulfonate, Betahistine; By Vertin; PT 9; PT9; Betaserc; Vasomotal; Betahistine Biphar;

MeSH CAS label : 2-Pyridineethanamine, N-methyl-;

MeSH Related Number : betahistine hydrochloride; betahistine mesylate; betahistine dihydrobromide; 54856-23-4 (mesylate); 5579-84-0 (di-HCl); 5638-76-6 (Betahistine); 64335-09-7 (di-HBr); 49K58SMZ7U;

Registry Number MeSH : 5638-76-6;

Related CAS MeSH : 54856-23-4 (Betahistine mesylate); 64335-09-7 (Betahistine dihydrobromide); 49K58SMZ7U (Betahistine hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Betahistine;

Codes EINECS : 227-086-4;

Is substance : O;

UNII : X32KK4201D;

InChIKey : UUQMNUMQCIQDMZ-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.

http://www.cochrane.org/fr/CD010696/betahistine-pour-le-traitement-des-symptomes-de-vertige
2020
false
false
false
France
United Kingdom
French
french abstract
vertigo
treatment outcome
betahistine
betahistine
review of literature

---
https://www.has-sante.fr/portail/jcms/c_2880788/fr/betahistine-arrow
2018
false
false
false
France
vertigo
dizziness
betahistine
evaluation of the transparency committee
betahistine

---
https://www.cochrane.org/fr/CD013093/betahistine-pour-le-traitement-des-acouphenes
2018
false
false
false
France
United Kingdom
betahistine
tinnitus
treatment outcome
Evidence-Based medicine
review of literature
french abstract

---
https://minerva-ebp.be/FR/Analysis/526
2017
false
false
false
Belgium
French
french abstract
pitta, nos
vertigo
betahistine
vertigo, nos

---
https://minerva-ebp.be/FR/Article/2063
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
histamine agonists
betahistine
longterm effects
meniere disease

---
http://www.has-sante.fr/portail/jcms/c_2678853/fr/extovyl
http://www.has-sante.fr/portail/jcms/c_1296228/extovyl
http://www.has-sante.fr/portail/jcms/c_477439/fr/extovyl
2016
false
France
French
evaluation of the transparency committee
betahistine
administration, oral
vertigo
insurance, health, reimbursement
betahistine
treatment outcome
Betahistine Mesylate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64943750
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69508759
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61044303
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65747224
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66569899
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63247099
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68210329
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65463708
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67885882
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65970533
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69401604
2012
France
summary of product characteristics
package leaflet
Betahistine Hydrochloride
betahistine
tablets

---
http://www.has-sante.fr/portail/jcms/c_1298550/betahistine-biogaran
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/betahistine_biogaran_05092012__avis_ct_12409.pdf
http://www.has-sante.fr/portail/jcms/c_539642/betahistine-biogaran
2012
France
French
betahistine
administration, oral
betahistine
insurance, health, reimbursement
vertigo
drugs, generic
treatment outcome
Betahistine Hydrochloride
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69923050
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60048672
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64212215
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62710021
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63091077
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60796491
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67477845
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61312160
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68907584
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60327056
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61528432
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62258445
2012
France
summary of product characteristics
package leaflet
betahistine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61324141
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65195943
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68850304
2012
France
summary of product characteristics
package leaflet
tablets
betahistine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66656546
2012
France
summary of product characteristics
package leaflet
Betahistine Hydrochloride
betahistine

---
http://www.has-sante.fr/portail/jcms/c_1198184/lectil
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/lectil_18012012_avis_ct11869.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_490538
2012
France
French
dizziness
Betahistine Hydrochloride
betahistine
administration, oral
vertigo
betahistine
insurance, health, reimbursement
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_486451
http://www.has-sante.fr/portail/jcms/c_1106800/betaserc-serc
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-10/betaserc-serc_05_10_2011_avis_10375.pdf
2011
France
French
betahistine
administration, oral
vertigo
insurance, health, reimbursement
betahistine
treatment outcome
dizziness
Betahistine Hydrochloride
evaluation of the transparency committee

---
http://www.cochrane.org/fr/CD001873
2011
false
true
false
France
United Kingdom
treatment outcome
review of literature
french abstract
betahistine
meniere disease

---
http://www.lecrat.eu/?s=B%C3%A9tahistine
2011
France
French
vasodilator agents
pregnancy
betahistine
histamine agonists
dizziness
vertigo
betahistine
Betahistine Mesylate
Betahistine Hydrochloride
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_539609
2007
France
evaluation of the transparency committee
betahistine
tablets

---
http://www.has-sante.fr/portail/display.jsp?id=c_399182
2001
France
evaluation of the transparency committee
tablets
betahistine

---
http://www.has-sante.fr/portail/display.jsp?id=c_399213
2001
France
evaluation of the transparency committee
tablets
betahistine

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.